Follow-up schedule | Screening/enrolment/baseline | Follow-up 1 | Subsequent Follow-ups |
---|---|---|---|
Timeline | Week −2 or 0a, b | Month 1 | Month 3 and every 3 months thereafterc |
Informed consent | X | Â | Â |
Review eligibility | X | X | X |
Medical historyd | X | Â | Â |
Renal function (creatinine clearance) | X | Â | Xe |
Serious adverse events, pregnancy (if applicable) | Â | X | X |
Hepatitis C testing | X | Â | Xf |
STI testing g | X | Â | X |
HIV testingg | X | X | X |
Dispense study medication | X | X | X |
Survey of adherence and behaviour | X | Â | Xh |